Literature DB >> 24286574

Epidemiology of heart failure and scope of the problem.

Longjian Liu1, Howard J Eisen.   

Abstract

Heart failure (HF) is typically a chronic disease, with progressive deterioration occurring over a period of years or even decades. HF poses an especially large public health burden. It represents a new epidemic of cardiovascular disease, affecting nearly 5.8 million people in the United States, and over 23 million worldwide. In the present article, our goal is to describe the most up-to-date epidemiology of HF in the United States and worldwide, and challenges facing HF prevention and treatment.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical correlation; Epidemiology; Heart failure; Multiple comorbidity

Mesh:

Year:  2014        PMID: 24286574     DOI: 10.1016/j.ccl.2013.09.009

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  53 in total

1.  Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF).

Authors:  Abel Makubi; Camilla Hage; Ulrik Sartipy; Johnson Lwakatare; Mohammed Janabi; Peter Kisenge; Ulf Dahlström; Lars Rydén; Julie Makani; Lars H Lund
Journal:  Int J Cardiol       Date:  2016-06-29       Impact factor: 4.164

Review 2.  Cost-effectiveness of cardiac resynchronization therapy plus an implantable cardioverter-defibrillator in patients with heart failure: a systematic review.

Authors:  Abedin Teimourizad; Aziz Rezapour; Saeed Sadeghian; Masih Tajdini
Journal:  Cost Eff Resour Alloc       Date:  2021-05-21

Review 3.  Systolic heart failure: knowledge gaps, misconceptions, and future directions.

Authors:  Rohan Samson; Rohit Ramachandran; Thierry H Le Jemtel
Journal:  Ochsner J       Date:  2014

4.  Tead1 is essential for mitochondrial function in cardiomyocytes.

Authors:  Ruya Liu; Rajaganapathi Jagannathan; Lingfei Sun; Feng Li; Ping Yang; Jeongkyung Lee; Vinny Negi; Eliana M Perez-Garcia; Sruti Shiva; Vijay K Yechoor; Mousumi Moulik
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-06-05       Impact factor: 4.733

Review 5.  Primary palliative care for heart failure: what is it? How do we implement it?

Authors:  Laura P Gelfman; Dio Kavalieratos; Winifred G Teuteberg; Anuradha Lala; Nathan E Goldstein
Journal:  Heart Fail Rev       Date:  2017-09       Impact factor: 4.214

Review 6.  The Initial Evaluation and Management of a Patient with Heart Failure.

Authors:  Jamael Hoosain; Jabar Whittier; Farhan Hasni; Shelley Hankins
Journal:  Curr Cardiol Rep       Date:  2017-09-06       Impact factor: 2.931

7.  Tead1 is required for maintaining adult cardiomyocyte function, and its loss results in lethal dilated cardiomyopathy.

Authors:  Ruya Liu; Jeongkyung Lee; Byung S Kim; Qiongling Wang; Samuel K Buxton; Nikhil Balasubramanyam; Jean J Kim; Jianrong Dong; Aijun Zhang; Shumin Li; Anisha A Gupte; Dale J Hamilton; James F Martin; George G Rodney; Cristian Coarfa; Xander Ht Wehrens; Vijay K Yechoor; Mousumi Moulik
Journal:  JCI Insight       Date:  2017-09-07

8.  Pharmacokinetics, Safety and Tolerability of Sacubitril/Valsartan (LCZ696) After Single-Dose Administration in Healthy Chinese Subjects.

Authors:  Yi Han; Surya Ayalasomayajula; Wei Pan; Fan Yang; Yaozong Yuan; Thomas Langenickel; Markus Hinder; Sampath Kalluri; Parasar Pal; Gangadhar Sunkara
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

9.  Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming.

Authors:  Tamer M A Mohamed; Nicole R Stone; Emily C Berry; Ethan Radzinsky; Yu Huang; Karishma Pratt; Yen-Sin Ang; Pengzhi Yu; Haixia Wang; Shibing Tang; Sergey Magnitsky; Sheng Ding; Kathryn N Ivey; Deepak Srivastava
Journal:  Circulation       Date:  2016-11-10       Impact factor: 29.690

Review 10.  From Bench to Bedside: New Approaches to Therapeutic Discovery for Heart Failure.

Authors:  Bianca C Bernardo; Burns C Blaxall
Journal:  Heart Lung Circ       Date:  2016-01-19       Impact factor: 2.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.